by Chris Melore WUHAN, China — As the worldwide number of COVID-19 cases reaches five million, the search for a vaccine has taken an important step forward. Researchers say the first human trial of a possible vaccine has been found to be safe and may effectively fight the virus. Scientists in China say 108 healthy adults were given...
As the cell’s protein factory, the ribosome is the only natural machine that manufactures its own parts. That is why understanding how the machine, itself, is made, could unlock the door to everything from understanding how life develops to designing new methods of drug production. An intensive, long research effort at the Weizmann Institute of...
by Eric Stirgus Dr. Lilly Immergluck last week gave what she called “the vaccine lecture” to a group of Morehouse School of Medicine students. Immergluck, a pediatrician, infectious disease specialist and an assistant professor at the Atlanta school since 2005, talks each year to all students there about how vaccines have helped control the spread...
A team at the University of California San Diego has developed a wearable, non invasive Vitamin C sensor that could provide a new, highly personalized option for users to track their daily nutritional intake and dietary adherence. The study was published in the journal ACS Sensors. “Wearable sensors have traditionally been focused on their use...
DALLAS, May 20, 2020 — Women receiving treatment in primary care received some cardiovascular medication prescriptions at a lower rate than men, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association. “Additional efforts need to be taken to ensure that everyone,...
An antibody appears to make a big difference between multiple sclerosis and other disorders affecting the protective myelin sheath around nerve fibres, report Tohoku University scientists and colleagues in the journal Brain. The finding suggests that some of these ‘inflammatory demyelinating diseases’ belong to a different category than multiple sclerosis, and should be treated according...
OAK BROOK, Ill. – Women with mammographically detected breast lesions that are probably benign should have follow-up surveillance imaging at six months due to the small but not insignificant risk that the lesions are malignant, according to a new study published in the journal Radiology. The Breast Imaging and Reporting System (BI-RADS) was established by...
by University of North Carolina at Chapel Hill School of Medicine The HIV Prevention Trials Network (HPTN) announced today results from HPTN 083, a global randomized, controlled, double-blind study that compared the safety and efficacy of long-acting injectable cabotegravir (CAB LA) to daily oral tenofovir/emtricitabine (TDF/FTC) (Truvada) for pre-exposure prophylaxis (PrEP). The study showed that...
By SASHA CUTTLER, MARY MAGEE, and GUY VANDENBERGMAY 18, 2020 As nurses who worked in 5B, the first U.S. hospital ward dedicated HIV/AIDS, which opened in San Francisco General Hospital in 1983, we have been directly affected in profound ways by the disease and its opportunistic infections. One of us is HIV-positive, infected from exposure...
Of all the hepatitis viruses, D is the most poorly known. This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied. Hepatitis D is one of the most dangerous forms of chronic viral hepatitis because of its possible progression to irreversible liver diseases (cancer and cirrhosis, in particular)....
